BLACK DIAMOND THERAPEUTICS, INC.
Last · —$1.70+0.02 (+1.19%)live · yahoo · 0s ago
Market cap$97.67M—
P/E · TTM4.9fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $70.0M |
|---|---|
| Operating income | $12.5M |
| Net income | $22.4M |
| Operating margin | 17.9% |
| Net margin | 32.0% |
| Return on equity | 19.9% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-16
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Accumulated Deficit High — Accumulated deficit / equity 414%
- Rd Intensity High — R&D/Revenue 47.9%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.06
Est. revenue
6.3M
Press & signals
- GlobeNewswire
Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update